Protagonist Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Protagonist Therapeutics by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.1M | 24k | 45.00 |
2024-06-30 | $520k | 15k | 34.65 |
2024-03-31 | $2.1M | 71k | 28.93 |
2023-12-31 | $10M | 446k | 22.93 |
2023-09-30 | $6.8M | 407k | 16.68 |
2023-06-30 | $27M | 975k | 27.62 |
2023-03-31 | $38M | 1.6M | 23.00 |
2022-12-31 | $30M | 2.7M | 10.91 |
2022-06-30 | $5.2M | 657k | 7.86 |
2022-03-31 | $8.5M | 361k | 23.68 |
2021-12-31 | $5.0M | 147k | 34.21 |
2021-09-30 | $7.6M | 427k | 17.73 |
2021-06-30 | $19M | 430k | 44.89 |
2021-03-31 | $5.4M | 208k | 25.90 |
2020-12-31 | $6.9M | 341k | 20.17 |
2020-03-31 | $3.3M | 469k | 7.06 |
2019-12-31 | $3.2M | 459k | 7.05 |
2019-09-30 | $5.0M | 416k | 12.01 |
2019-06-30 | $5.0M | 410k | 12.11 |
2019-03-31 | $4.6M | 364k | 12.57 |
2018-12-31 | $234k | 35k | 6.73 |
2018-09-30 | $368k | 36k | 10.29 |
2018-06-30 | $883k | 131k | 6.72 |
2018-03-31 | $423k | 49k | 8.60 |